Linda Johnson

AP Business Writer

Freeing From Dock Scheduling Chaos

Freeing From Dock Scheduling Chaos

June 25, 2026

The MR-X from Mantis Robotics is a biomimetic dual-arm robot.

Mantis Robotics Debuts MR-X Dual-Arm Fenceless Robot at Automate 2026

June 26, 2026

SendCutSend has transitioned from serving small-scale inventors to supporting large-scale enterprise production.

5 Things You Should Know Before Using an On-Demand Manufacturer

June 25, 2026

Keytronic Expands in Mississippi, Adding 376 Jobs

June 25, 2026

The Security Breach Podcast

The Security Breach Podcast

Security Breach from Manufacturing.net offers the insight needed to ready your company's defenses against hackers.

June 19, 2026

In this file photo, a pharmacist holds a vial of the Johnson & Johnson COVID-19 vaccine.

FDA Found Problems at J&J Vaccine Factory

The issues ranged from poorly trained employees to cracked vials to mold around one of its facilities.

April 21, 2021

President Joe Biden speaks about efforts to combat COVID-19, in the State Dining Room of the White House, Tuesday, March 2, 2021, in Washington.

Biden Vows Enough Vaccine for All US Adults by End of May

Biden’s announcements quickly raised expectations for when the nation could safely emerge from the pandemic.

March 3, 2021

Mike McDermott, president of global supply since 2019.

Insider Q&A: Pfizer Exec on Ramping Up Vaccine Supply

"We look at reducing wait times when changing over between batches, doubling of our batch size, increasing yields per batch."

February 15, 2021

This Sept. 2020 photo provided by Johnson & Johnson shows a clinician preparing to administer investigational Janssen COVID-19 vaccine.

J&J 1-Dose Shot Works, Less Effective Than Others

It appears to protect against COVID-19, but not as strongly as some two-shot rivals.

January 29, 2021

In this Nov. 9, 2020, file photo, pedestrians walk past Pfizer world headquarters in New York. Pfizer announced Wednesday, Nov. 18, 2020, more results in its ongoing coronavirus vaccine study that suggest the shots are 95% effective a month after the first dose.

Pfizer: COVID-19 Shot 95% Effective, Seeking Clearance Soon

New data suggests the vaccine works even better than Pfizer initially reported.

November 18, 2020

I Stock 1154450279

Pfizer Says COVID-19 Vaccine Looks 90% Effective

The data would put the company on track to apply for emergency-use approval from the FDA.

November 9, 2020

A single-dose COVID-19 vaccine being developed by Johnson & Johnson.

Late-Stage Study of First Single-Shot Vaccine Begins in US

U.S. health officials insist the race for a vaccine isn't cutting corners.

September 23, 2020

Insulin Makers Offer it Free or Cheap

All top three insulin makers are now offering programs to help patients.

April 14, 2020

Johnson's Baby Aloe & Vitamin E Powder in Salt Lake City. Johnson & Johnson reports financial results Tuesday, April 14, 2020.

J&J Races to Develop Vaccine

The company also cut billions from its forecast on higher related costs and fewer sales.

April 14, 2020

This undated photo provided by the U.S. Attorney's Office shows a phony coronavirus cure that a British man tried to smuggle into the United States. Con artists are finding lots of marks amid the COVID-19 pandemic. Watchdog groups and authorities report a surge of complaints about scams targeting people who fear catching the virus or need money due to lost income.

COVID-19 Cure Cons Rampant

Americans filed complaints about losses to coronavirus-related fraud totaling nearly $6 million.

April 8, 2020

In this July 8, 2016, file photo, a pharmacist holds a package of EpiPens epinephrine auto-injector, a Mylan product, in Sacramento, Calif. On Tuesday, March 24, 2020, the U.S. Food and Drug Administration warned the public about malfunctions involving some EpiPens, the emergency injectors for severe allergic reactions.

EpiPens Could Harm Patients

The malfunctions can prevent or delay the devices from injecting the drug or cause them to eject it prematurely.

March 24, 2020

U.S. Food and Drug Administration building behind FDA logos at a bus stop on the agency's campus in Silver Spring, Md.

Companies Warned Over Virus Claims

The companies are selling soaps, sprays and other concoctions with false claims that they can treat the new coronavirus or keep people from catching it.

March 10, 2020

This Aug. 2, 2018, file photo shows the U.S. Food and Drug Administration building behind FDA logos at a bus stop on the agency's campus in Silver Spring, Md. Health officials reported the first U.S. drug shortage tied to the viral outbreak that is disrupting production in China, but they declined to identify the manufacturer or the product. The Food and Drug Administration said late Thursday, Feb. 27, 2020, that the drug's maker contacted health officials recently about the shortage, which it blamed on a manufacturing issue with the medicine's key ingredient.

Drug Shortage Tied to Outbreak

The drug's maker contacted officials about the shortage, which it blamed on a manufacturing issue with the medicine's key ingredient.

March 2, 2020

I Stock 1135337514

Weight Loss Drug Pulled

The company still believes Belviq's benefits outweigh the cancer risk.

February 14, 2020